Practical Approach to Management of Inpatient Hyperglycemia in Select Patient Populations

References

• . Wang CC, Draznin B. Insulin use in hospitalized patients with diabetes: navigate with care. Diabetes Spectrum. In press
   Google Scholar
• . Olefsky JM, Kimmerling G. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci. 1976;271(2):202–210
   PubMedGoogle Scholar
• . Kaihan SC, Adam PA. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. J Clin Endocrinol Metab. 1975;41(3):600–610
   PubMedGoogle Scholar
• . Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs. 1978;16(3):238–255
   PubMedGoogle Scholar
• . van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34(2):412–117
   PubMed Web of Science ®Google Scholar
• . Seggelke SA, Gibbs J, Draznin B. Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med. 2011;6(3):175–176
   PubMed Web of Science ®Google Scholar
• . Rasouli N, Seggelke S, Gibbs J, . Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. J Diabetes Sci Technol. 2012;6(5):1038–1044
   PubMedGoogle Scholar
• . Lukins MB, Manninen PH. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg. 2005;100(4):1129–1133
   PubMedGoogle Scholar
• . Ricks J, Molnar MZ, Kovesdy CP, . Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes. 2012;61(3):708–715
   PubMedGoogle Scholar
• . Oomichi T, Emoto M, Tabata T, . Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care. 2006;29(7):1496–500
   PubMedGoogle Scholar
• . Kalantar-Zadeh K, Kopple JD, Regidor DL, . A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30(5):1049–1055
   PubMedGoogle Scholar
• . Hoshino J, Molnar MZ, Yamagata K, . Developing an HbA1c-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care. 2012;36(4):922–927
   PubMedGoogle Scholar
• . Murea M, Moran T, Russell GB, . Glycated albumin, not hemoglobin Alc, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Am J Nephrol. 2012;36(5):488–496
   PubMedGoogle Scholar
• . Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, . Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care. 2009;32(7):1137–1142
   PubMedGoogle Scholar
• . Riveline JP, Teynie J, Belmouaz S, . Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant. 2009;24(9):2866–2871
   PubMedGoogle Scholar
• . Sobngwi E, Enoru S, Ashuntantang G, . Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis. Diabetes Care. 2010; 33(7):1409–1412
   PubMed Web of Science ®Google Scholar
• . Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant. 2007;22(3):870–879
   PubMedGoogle Scholar
• . Penneil P, Rojas C, Asif A, Rossini E. Managing metabolic complications of peritoneal dialysis. Clin Nephrol. 2004;62(1):35–43
   PubMedGoogle Scholar
• . Nevalainen P, Lahtela JT, Mustonen J, Pasternack A. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients. Nephrol Dial Transplant. 1997;12(1):145–150
   PubMedGoogle Scholar
• . Lahtela JT, Mustonen J, Pasternack A. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment. Clin Sci (Lond). 1995;88(4):427–132
   PubMedGoogle Scholar
• . Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med. 2009;361(11):1088–1097
   PubMed Web of Science ®Google Scholar
• . Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28(10):2367–2371
   PubMedGoogle Scholar
• . Olveira G, Tapia MJ, Ocon J, . Parenteral Nutrition-Associated Hyperglycemia in Noncritically Ill—Inpatients Increases the Risk of In-hospital Mortality (Multicenter Study): Study Group of Hyperglycemia in Parenteral Nutrition: Nutrition Area of the Spanish Society of Endocrinology and Nutrition (SEEN) [published online ahead of print December 6, 2012]. Diabetes Care.
   Google Scholar
• . Jakoby MG, Nannapaneni N. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JPEN. 2012;36(2):183–188
   PubMedGoogle Scholar
• . Baldwin D, Kinnare K, Draznin B, . Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN) [abstract]. Diabetes. 2012;61[ suppl 1]: A275
   Google Scholar
• . Umpierrez GE. Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care. 2009;32(4):751–753
   PubMedGoogle Scholar
• . Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract. 2011;26(6):714–717
   PubMedGoogle Scholar
• . Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10( suppl 2):71–80
   PubMedGoogle Scholar
• . Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343
   PubMed Web of Science ®Google Scholar
• . Hsia E, Seggelke S, Gibbs J, . Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–3137
   PubMed Web of Science ®Google Scholar
• . Avanzini F, Marelli G, Donzelli W, . Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care. 2011;34(7):1445–1450
   PubMedGoogle Scholar
• . Ramos P, Childers D, Maynard G, . Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach. J Hosp Med. 2010;5(8):446–151
   PubMedGoogle Scholar
• . Weant KA, Ladha A. Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients. Ann Pharmacother. 2009;43(4):629–634
   PubMedGoogle Scholar
• . Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006;98(4):557–564
   PubMedGoogle Scholar
• . Schmeltz LR, DeSantis AJ, Schmidt K, . Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006;12(6):641–650
   PubMedGoogle Scholar
• . Czosnowski QA, Swanson JM, Lobo BL, Broyles JE, Deaton PR, Finch CK. Evaluation of glycemic control following discontinuation of an intensive insulin protocol. J Hosp Med. 2009;4(1):28–34
   PubMedGoogle Scholar
• . Boord JB, Greevy RA, Braithwaite SS, . Evaluation of hospital glycemic control at US academic medical centers. J Hosp Med. 2009;4(1):35–14
   PubMedGoogle Scholar
• . Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML. Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med. 2006;1(3):145–150
   PubMed Web of Science ®Google Scholar
• . Matheny ME, Shubina M, Kimmel ZM, Pendergrass ML, Turchin A. Treatment intensification and blood glucose control among hospitalized diabetic patients. J Gen Intern Med. 2008;23(2):184–189
   PubMed Web of Science ®Google Scholar
• . Umpierrez GE, Hellman R, Korytkowski MT, . Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38
   PubMed Web of Science ®Google Scholar
• . Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4(1):3–15
   PubMed Web of Science ®Google Scholar
• . Deal EN, Liu A, Wise LL, Honick KA, Tobin GS. Inpatient insulin orders: are patients getting what is prescribed? J Hosp Med. 2011;6(9):526–529
   PubMedGoogle Scholar
• . Giangola J, Olohan K, Longo J, Goldstein JM, Gross PA. Barriers to hyperglycemia control in hospitalized patients: a descriptive epidemiologic study. Endocr Pract. 2008;14(7):813–819
   PubMedGoogle Scholar
• . Shankar V, Haque A, Churchwell KB, Russell W. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intensive Care Med. 2007;33(7):1173–1178
   PubMedGoogle Scholar
• . Inzucchi SE, Bergenstal RM, Buse JB, . Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577–1596
   PubMed Web of Science ®Google Scholar